Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. - Wikidata - awgldk - TriplyDB

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

http://www.wikidata.org/entity/Q34860779

about

α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease Glia and alpha-synuclein in neurodegeneration: A complex interaction Alzheimer's disease pathologic cascades: who comes first, what drives what Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease Alpha-synuclein and tau: teammates in neurodegeneration?DNAJC13 mutations in Parkinson disease Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects Variants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample.Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.Motor and cognitive deficits in aged tau knockout mice in two background strains.Tau reduction does not prevent motor deficits in two mouse models of Parkinson's disease Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study.H1-MAPT and the risk for familial essential tremor Evaluation of the role of SNCA variants in survival without neurological disease PART is part of Alzheimer disease.PART, a distinct tauopathy, different from classical sporadic Alzheimer disease.A powerful yeast model to investigate the synergistic interaction of α-synuclein and tau in neurodegeneration.A new association test based on disease allele selection for case-control genome-wide association studies.SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.The Evolution of Genetics: Alzheimer's and Parkinson's Diseases.Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16.Association studies of sporadic Parkinson's disease in the genomic era.Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts.Genetic variability in SNCA and Parkinson's disease.Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study.Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.A prognostic view on the application of individualized genomics in Parkinson's disease.SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.Association analysis of the GRN rs5848 and MAPT rs242557 polymorphisms in Parkinson's disease and multiple system atrophy: a large-scale population-based study and meta-analysis.SNCA rs356219 variant increases risk of sporadic Parkinson's disease in ethnic Chinese.Multiple system atrophy: genetic risks and alpha-synuclein mutations.MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome.A Comprehensive Analysis of the Association Between Polymorphisms and the Risk of Parkinson's Disease

P2860

Q21090919-A118793E-54BA-4ACB-8900-85B7434BB294 Q26851153-8D15B383-E3E5-4FDB-AF2B-1D80FBC7A8BE Q26995896-D217A710-FD08-449B-8580-CA5B799EF567 Q28244731-DEB6BDF7-2D39-4CB7-8041-EA02CABC84E7 Q28250508-D93AC65E-7C6E-4FFE-9912-B208038515D2 Q28658355-D7BA3FB5-80F5-4CA0-8701-0280208D2A46 Q33734084-F38DF819-7A1D-4EEC-A781-67DEFEF2AF0C Q33813336-37B8E3D2-A924-483B-B71A-ACA3D84A1C24 Q33939245-C9B14143-6C0C-4638-A90D-2579C46D05FB Q34077327-EF6E8C44-53A6-4E0C-8C62-B0B21B65FD9F Q34113712-C0AD296E-E880-4AF7-9899-179B906C330C Q34198178-FC86418F-E2E2-4FF0-9B20-E36AFE1D332B Q34388030-C9D42B0C-A620-4271-9725-9AA58283CCBC Q34389030-F69C6195-30F1-470D-93AB-069DA3C005B2 Q34460027-F0BECC50-4481-4CFB-86C9-C32C50D5EEDA Q34467464-DF281AF3-7D06-4BBF-B005-4592D440C55A Q34581042-8E106CE1-A043-41BE-9FB5-01C499019BD0 Q35179367-BC908577-BDFF-4C60-A709-D6436F24D5AA Q35859538-2547F791-0FA9-45B1-B6EE-1FDD9F25C51A Q35988441-9893C955-BCC1-4323-877F-328BA2F4E992 Q36395549-E7D53C45-0CD9-421C-A4C0-DDC8E098A8B4 Q37074331-14400359-244B-4993-ABB5-CB7C4FB8815F Q37312762-A54E29C1-D4A8-4A38-82E5-1A6E44E1AC74 Q37367002-0833CAE0-EE6A-48B3-9841-4ECC2F2F7EBC Q37645620-0969271A-054B-4F31-8B54-8B2FB28CF4E2 Q37874476-DCC82F6F-8879-4BA3-8114-A1CA364D42F0 Q37907930-2B7B7684-1378-45E8-98DE-D01190E52225 Q37955871-AEC8B125-972C-4428-862D-2DC3D31526D0 Q38637878-41E42E3D-D199-4FBD-B0D6-A73A47F472C4 Q38954686-30107739-694B-4B5B-8E2B-0495233C0C1D Q39103104-9FE2D9CC-F3F2-4BB4-98DB-9E1CF2740104 Q39214168-480955AE-98DB-41D1-9FDC-4D7CCD54F446 Q39237805-50E72BEF-0C2C-4AC2-B660-FF8808A31483 Q39450010-3486B1B7-4E77-4FF1-8EC2-99A5F3104B8D Q40047619-EA588F12-04BE-4EF0-BEF1-C27BE6E956D7 Q40612239-2B12C50C-0889-4134-A096-98C865A6E2CC Q43521013-7D66A7DC-3ADA-4649-BD8E-FF89C92A5EEF Q47309944-D1EEFC46-2C70-45F8-B426-B2AD72FED3BD Q54290859-0721F794-B8DF-45B6-B423-D5EA28ADD01D Q58556450-65794C1D-B060-4A9F-B1D3-CA026288D9EF

P2860

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

http://www.wikidata.org/entity/Q34860779

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

@ast

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

@en

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

@nl

type

label

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

@ast

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

@en

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

@nl

prefLabel

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

@ast

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

@en

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

@nl

P1433

Q34860779-F7C8E3BD-BB68-43D2-AADC-02F010CE434B

P1476

Q34860779-274D8039-3479-4CA8-9B18-EB2851125894

P2093

Q34860779-1E761482-6504-467E-B8D8-3774DA183FC8

Q34860779-217278A9-AAB7-43DB-92AC-92216BF9CEA0

Q34860779-21D66ABC-6E1A-4598-806A-290AFFE004B5

Q34860779-262BADD9-BE55-4E84-8BEA-211963261744

Q34860779-27DB9148-56C9-45AD-9376-7A126F16EE06

Q34860779-2C671118-DF03-4153-AFCD-40BF1B64F68B

Q34860779-53D8585E-5268-43D3-BF24-A1D68AA62FEB

Q34860779-5EEC2829-29BA-400B-B31A-AD72DCADF129

Q34860779-64E60D1E-12F4-42BC-820E-E9FD741E51F9

Q34860779-6B10FEC8-FE01-467D-8E20-C207671C8441

P2860

Q34860779-036CACB2-D8A1-4527-AEBE-E708F9F92F6B

Q34860779-0C832F82-2B72-4DD3-8B83-95C9EC9C504A

Q34860779-126280F1-F4E7-4A98-A1C8-AECE8B5836BC

Q34860779-16CBE6F0-44B8-436B-B2C6-63257EBC7CBB

Q34860779-1D8F0805-118A-405D-8A8C-64EDBEB2097E

Q34860779-22D36D1D-3880-44DA-938E-EB9853C6B755

Q34860779-254D5AB7-43B6-487A-8FEE-B59CA612EA60

Q34860779-281C49D7-DC46-4D09-A52E-917B334CB9FC

Q34860779-2C573E3B-BB03-4DD1-A376-302A227168AB

Q34860779-3A0560ED-4E81-4F58-B589-317D615CEAA6

P304

Q34860779-2434C64A-2A47-47FF-B575-666121AE10F6

P31

Q34860779-0003A37C-7183-455A-9D17-5F0637F52843

Q34860779-9346deda-c78e-4576-9c10-0248d648cce5

P356

Q34860779-80DD74D9-64C3-4119-A402-E2276E7EC813

P433

Q34860779-9764B7FF-136D-4A6D-A6C4-BFD73F6748C9

P478

Q34860779-D87A9914-97D9-4B67-A488-0D0C9C141FAB

P50

Q34860779-17564D7C-0964-4088-810B-4F8969936047

Q34860779-2D6F3891-E2AA-43EA-A527-52160A7DB090

Q34860779-340A634E-F981-47DE-93FC-7A9119CC6CC6

Q34860779-3436BFDE-8E12-4412-9E5D-382930610CAD

Q34860779-3AEC2BFF-D347-409A-8037-5D3DB1E18638

Q34860779-3B91422C-DA2F-40E9-920B-2FC29E76FC4C

Q34860779-3CE694EE-4073-4DEF-9993-F06D73BB4E96

Q34860779-422361A9-8C39-4266-8252-45F93B0F683B

Q34860779-55910DEA-9250-4AC7-8501-6B16A7F7B3C2

Q34860779-5CE9F2BF-E39E-4272-8208-3AEF423E4FD8

P577

Q34860779-6AB3CBD5-2473-4D30-9451-05A76302D7CA

P5875

Q34860779-C12E3612-266B-4C72-9968-F57AF2D54183

P698

Q34860779-EDFBF996-3AA3-48EC-97E6-9659A8EDD82A

P921

Q34860779-54FE1016-A3E1-4EF8-9E9E-EEAE1B146DD8

P932

Q34860779-28456ACE-A802-47DC-AF1E-42C39139D021

P356

P1433

Annals of Neurology

P1476

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

@en

P2093

Alain Destée

http://www.w3.org/2001/XMLSchema#string

Alessandro Ferraris

http://www.w3.org/2001/XMLSchema#string

Alexandra I Soto-Ortolaza

http://www.w3.org/2001/XMLSchema#string

Alexis Elbaz

http://www.w3.org/2001/XMLSchema#string

Carlo Ferrarese

http://www.w3.org/2001/XMLSchema#string

Christer Nilsson

http://www.w3.org/2001/XMLSchema#string

Demetrius M Maraganore

http://www.w3.org/2001/XMLSchema#string

Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium

http://www.w3.org/2001/XMLSchema#string

Georgia Xiromerisiou

http://www.w3.org/2001/XMLSchema#string

Georgios M Hadjigeorgiou

http://www.w3.org/2001/XMLSchema#string

P2860

Epistasis--the essential role of gene interactions in the structure and evolution of genetic systems

Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease

Genome-wide association study reveals genetic risk underlying Parkinson's disease

Quantifying heterogeneity in a meta-analysis

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

Performing the exact test of Hardy-Weinberg proportion for multiple alleles

Genomewide association study for susceptibility genes contributing to familial Parkinson disease

Meta-analysis of continuous outcome data from individual patients.

Meta-analysis of ordinal outcomes using individual patient data.

A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes

P304

778-792

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.22321

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Christine Klein

Carles Vilariño-Güell

Enza Maria Valente

Jean-Charles Lambert

Karin Wirdefeldt

Matthew J. Farrer

George D. Mellick

Marie-Anne Loriot

Andreas Puschmann

P577

2011-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50353200

http://www.w3.org/2001/XMLSchema#string

P698

21391235

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3082599

http://www.w3.org/2001/XMLSchema#string